PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaAll Plans · Coverage · Medical Policy · Wound Care, Podiatry, Plastic Surgery +2 moreMedium impact

Skin and Soft Tissue Substitutes (CPB 0244, reviewed 2026-07-29)

Effective date
Not stated in the notice
Identified
Aug 16, 2026

Summary

Aetna's Clinical Policy Bulletin 0244 sets the coverage rules for skin and soft tissue substitutes used on chronic wounds. Aetna considers these products medically necessary for chronic wounds that failed to respond to treatment when the member is 18 or older, is a non-smoker or has completed or is enrolled in smoking cessation therapy, and the wound is a partial- or full-thickness skin defect of at least 1 cm2 that has not improved after at least four weeks of standard wound care. Diabetic foot ulcers, venous leg ulcers and partial- or full-thickness burn wounds have additional criteria, each listed product has its own indications, and pressure ulcer treatment and other uses are considered not medically necessary, experimental, investigational or unproven.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 6 steps
01Billing team: For these services, the source requires a wound characteristics and treatment plan submission that includes a photo with a ruler, and an attestation that the member is a non-smoker or has completed or is currently enrolled in smoking cessation therapy.
02The record must show at least four weeks of standard wound care, including debridement, standard dressings and elimination of underlying contributing factors (for diabetic foot ulcers, compression and off-loading as well).
03For continued treatment, wound measurements must be taken no more than 14 days apart and show progressive healing, with photographic documentation with a ruler and evidence in the medical record that the wound is improving.
04Continued treatment is limited to 10 applications or treatments per 12-week period of care, only one skin or soft tissue substitute product may be in place per wound episode, and treatment beyond 12 weeks is considered not medically necessary.
05For Apligraf (Q4101), Epifix (Q4186) and the other listed products, bill with the diagnosis codes the source lists for that product when selection criteria are met.
06Keep the documentation available on request for coverage determination, quality improvement, and fraud, waste and abuse prevention reviews, which may include patient records, test results and provider credentials.

Codes mentioned

15271152781577797597975981104211045Q4101Q4105Q4116Q4132Q4133Q4102Q4107Q4130Q4121Q4186Q4187Q4122Q4151Q4128Q4115Q4182Q4104C9363E08.621E09.621E10.621E11.621E13.621Q81.2Z72.0Z87.730

Original notice

Skin and Soft Tissue Substitutes (CPB 0244, reviewed 2026-07-29)
aetna.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account